NORFOLK, Va.--(BUSINESS WIRE)--Beaufort, a global contract research organization that partners with in vitro diagnostic (IVD), medical device and biopharmaceutical developers to provide clinical and regulatory services and a full range of quality and staffing solutions, will celebrate its tenth year as a member of the Association of Medical Diagnostics Manufacturers (AMDM). The company is sponsoring the AMDM Annual Meeting, April 22–23 in North Bethesda, MD, and will participate in two seminars.
“Our clients have relied on our team’s perspective for best practices and coming trends in IVD research for more than a decade,” said Schuyler Ritter, Beaufort senior vice president of business development and cofounder.
Beaufort recently hired Robert Di Tullio as senior vice president of global regulatory services and Melissa Barhoover, Ph.D., RAC, as clinical and regulatory affairs manager. Both will speak at the AMDM Annual Meeting on topics that reflect their areas of expertise and Beaufort’s services.
In Vitro Companion Diagnostic Device Case Studies
Wednesday, April 22, 3:15–3:45 p.m., presented by Melissa Barhoover, Ph.D., RAC
The Changing Regulatory and Policy Environment for Diagnostics:
What to Expect in 2015 and Beyond
Thursday, April 23, 9–9:45 a.m., presented by Robert Di Tullio
Di Tullio has 40 years’ experience in the IVD industry, including nearly three decades in regulatory, clinical and quality management. Di Tullio’s strategic expertise will help Beaufort’s clients achieve success while ensuring compliance with global regulations and initiatives. Barhoover’s background stems from 15 years of experience in clinical chemistry and molecular biology as well as project management and regulatory affairs for IVD development.
“These individuals are deeply embedded in the IVD industry,” said Ritter. “Their expertise in clinical and regulatory affairs will further our ability to provide customized, reliable and effective solutions.”
For more information, visit beaufortcro.com.
Beaufort is a contract research organization that provides in vitro diagnostic, medical device and biopharmaceutical clinical and regulatory services, and a full range of quality solutions and staffing solutions. For more than a decade, companies worldwide have trusted Beaufort for its client-oriented approach to research. With operations spanning the globe, Beaufort has a proven track record working closely with clients and regulatory agencies internationally to bring complex and therapeutic-specific products to market. Learn more at beaufortcro.com.